Clinical Trial Update: Remotely Administered Diet Intervention to Impact Symptom Burden in Myeloproliferative Neoplasm [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a remotely administered diet intervention to reduce symptom burden in patients with myeloproliferative neoplasm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasm

Snippet

Sponsor: University of California, Irvine | Conditions: Myeloproliferative Neoplasm | Phase 2 | Status: COMPLETED